PLANTATION, Fla., Jan. 6, 2014 /PRNewswire/ -- Neurotrope, Inc. (OTCQB: NTRP) (the "Company") announced today that the Company will present at the Biotech Showcase 2014 conference 8:00AM Pacific Time on Monday, January 13, 2014 at the Parc 55 Wyndham Hotel, Union Square in San Francisco, California.
The Company will discuss its unique position as it works towards commercializing certain technologies that were initially developed by the Blanchette Rockefeller Neurosciences Institute and its affiliates, for the diagnosis of and treatment of Alzheimer's Disease. The Company's core research program is targeted towards developing novel therapeutic modalities to treat a variety of neurodegenerative pathologies. Details of the Company's initiatives for 2014 will also be provided.
Neurotrope, Inc. will webcast its corporate presentation at:
The webcast may also be accessed on the Company's website, www.neurotropebioscience.com. The webcast can be accessed live and will be available for replay after the presentation on the Company's website.
About Biotech Showcase
Biotech Showcase™ is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco during this critical week which is widely viewed as setting the tone for the coming year.
Neurotrope was formed in October 2012 to develop and market two product platforms, includi
|SOURCE Neurotrope, Inc.|
Copyright©2012 PR Newswire.
All rights reserved